These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1212 related items for PubMed ID: 18349295

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ.
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F, Ormeci N, Coban S, Karabulut HG, Aktas B, Tukun A, Tuncali T, Yüksel O, Alkış N.
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [Abstract] [Full Text] [Related]

  • 26. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A, Ochs-Balcom H, Falk G, Grady WM, Kinnard M, Willis JE, Elston R, Eng C.
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [Abstract] [Full Text] [Related]

  • 27. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
    Moriyama N, Amano Y, Mishima Y, Okita K, Takahashi Y, Yuki T, Ishimura N, Ishihara S, Kinoshita Y.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
    [Abstract] [Full Text] [Related]

  • 28. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J, Hopwood D, Pringle R, Wormsley KG.
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [Abstract] [Full Text] [Related]

  • 29. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
    Menke V, Van Zoest KP, Moons LM, Pot RG, Siersema PD, Kuipers EJ, Kusters JG.
    Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
    [Abstract] [Full Text] [Related]

  • 30. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A, Hallas J, de Muckadell OB.
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [Abstract] [Full Text] [Related]

  • 31. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.
    Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL.
    Carcinogenesis; 2005 Sep; 26(9):1536-41. PubMed ID: 15878910
    [Abstract] [Full Text] [Related]

  • 32. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
    Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, Imatani A, Kato K, Shimosegawa T.
    Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
    [Abstract] [Full Text] [Related]

  • 33. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
    Oh DS, DeMeester SR, Vallbohmer D, Mori R, Kuramochi H, Hagen JA, Lipham J, Danenberg KD, Danenberg PV, Chandrasoma P, DeMeester TR.
    Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
    [Abstract] [Full Text] [Related]

  • 34. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro LF, Yelamos J, Molina J.
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [Abstract] [Full Text] [Related]

  • 35. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK.
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [Abstract] [Full Text] [Related]

  • 36. Reflux esophagitis and carcinoma.
    Ribet ME, Mensier EA.
    Surg Gynecol Obstet; 1992 Aug; 175(2):121-5. PubMed ID: 1636135
    [Abstract] [Full Text] [Related]

  • 37. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4784-92. PubMed ID: 15269153
    [Abstract] [Full Text] [Related]

  • 38. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
    Vallböhmer D, DeMeester SR, Oh DS, Banki F, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, Chandrasoma PT, Peters JH, DeMeester TR.
    Am J Gastroenterol; 2006 Jul 15; 101(7):1458-66. PubMed ID: 16863546
    [Abstract] [Full Text] [Related]

  • 39. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T, Hart J, Smith KD, Mezhir JJ, Weichselbaum RR, Khodarev NN.
    Cancer Res; 2005 Apr 15; 65(8):3146-54. PubMed ID: 15833844
    [Abstract] [Full Text] [Related]

  • 40. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
    Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyrén O.
    Carcinogenesis; 2006 Sep 15; 27(9):1835-41. PubMed ID: 16571649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.